First Cat-Specific Blood Pressure Drug Approved — and the FDA File Shows Why Catching It Late Costs Vision
On April 29, 2026 the FDA approved AMODIP (amlodipine besylate chewable tablets, Ceva) — the first cat-specific drug for systemic hypertension in cats. In the field study systolic pressure fell 28.2 mmHg on average by Day 28. But the same FDA file notes that cats whose vision was already severely lost at treatment start were less likely to regain it even after the retina reattached. Feline hypertension travels with kidney disease and is invisible at home. What to do now.

What Was Approved

Wondering if this applies to your cat?
Just read the news? Check your own cat now with CatsMe — one photo, instant AI health score.
Used by 380,000+ cat owners in 50 countries
Feline Hypertension Travels With Kidney Disease — and Shows You Nothing at Home
The Real Story Is One Sentence in the FDA File
Cats that had severe fundic lesions and severely decreased or absent vision at the start of treatment were less likely to regain visual function, despite retinal reattachment and improvement in retinal hemorrhages.
What To Do Now: Start by Asking for the Measurement
Turn Invisible Change Into a Record — CatsMe
Stay ahead of your cat’s health
CatsMe automatically logs daily health scores you can share with your vet in one tap — so you’re never left guessing.
FAQ

Be ready the moment you sense something's off
Take one photo and the AI reads pain and condition from your cat's expression. Check the moment you wonder, and share the record with your vet.